Pfizer Acquires a Stem-Cell Therapy

Pfizer said Sunday that it was buying the rights to a somewhat controversial cell therapy from Athersys, a biotechnology company — a sign of big pharmaceutical companies’ growing interest in stem cells.

Pfizer will have the rights to develop Athersys’s cells to treat inflammatory bowel disease, the companies are expected to announce on Monday. It will pay Athersys $6 million initially and up to $105 million in the future.

read more:

Incoming search terms:

stemgenex complaints, stemgenex reviews, stemgenex cost, Athersys Fraud, stemgenex review, reviews of stemgenex, stemgenex MS reveiws, stemgenex fraud, is stemgenex legit, stemgenex testimonials, stemgenex paient complaints, StemGenex Treatment complaints, stem genex review, pfizer and stem cells, stem genex reviews, stemgenex testimonials ms, Pfizer cell therapy, pfizer stem cell research, pfizer stem cell therapy 2014, reviews from patients that had procedure at Stemgenex, stem genex ms reviews, stemgenex customer complaints, stemedix complaints com.

One thought on “Pfizer Acquires a Stem-Cell Therapy”

Leave a Reply

Your email address will not be published.

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>